J Bacteriol 2004,186(9):2612–2618 PubMedCrossRef 42 Merien F,

J. Bacteriol. 2004,186(9):2612–2618.PubMedCrossRef 42. Merien F, Truccolo J, Baranton G, Perolat P: Identification of a 36-kDa fibronectin-binding protein expressed by a virulent variant of Leptospira interrogans serovar icterohaemorrhagiae. FEMS Microbiol. Lett. 2000,185(1):17–22.PubMedCrossRef 43. Hoke DE, Egan S, Cullen PA, Adler B: LipL32 is an extracellular matrix-interacting protein of Leptospira spp. and Pseudoalteromonas tunicata. Infect.

Immun. 2008,76(5):2063–2069.PubMedCrossRef 44. Hoke DE, Egan S, Cullen PA, Adler B: LipL32 is an extracellular matrix-interacting protein of Leptospira spp. and Pseudoalteromonas tunicata. Infect. Immun. 2008,76(5):2063–2069.PubMedCrossRef 45. Pinne M, Choy HA, Haake DA: The OmpL37 surface-exposed protein is expressed by pathogenic Leptospira during infection and binds skin and vascular elastin. PLoS neglected tropical diseases  ,4(9):e815.CrossRef 46. Félix SR, Hartwig DD, Argondizzo AP, Selleck BIBF-1120 Silva EF, Seixas FK, Seixas Neto AC, Medeiros

MA, Lilenbaum W, Dellagostin OA: Evaluation of the Immune Protective Potential CSF-1R inhibitor of Leptospiral Antigens: a Subunit Approach. Clin Vaccine Immunol 2011,18(11): . 47. Fenno JC, Tamura M, Hannam PM, Wong GW, Chan RA, McBride BC: Identification of a Treponema denticola OppA homologue that binds host proteins present in the subgingival environment. Infect. Immun. 2000,68(4):1884–1892.PubMedCrossRef 48. LeBouder F, Morello E, Rimmelzwaan GF, Bosse F, Pechoux C, Delmas B, Riteau B: Annexin II incorporated into influenza virus particles supports virus replication by converting plasminogen into plasmin. J. Virol. 2008,82(14):6820–6828.PubMedCrossRef 49. Rojas M, Labrador I, Concepcion JL, Aldana E, Avilan L: Characteristics of plasminogen binding to Trypanosoma cruzi epimastigotes. Acta Trop. 2008,107(1):54–58.PubMedCrossRef 50.

Klempner MS, Noring R, Epstein MP, McCloud B, Rogers RA: Binding of human urokinase type plasminogen activator and plasminogen to Borrelia species. J. Infect. Dis. 1996,174(1):97–104.PubMedCrossRef 51. Ponting CP, Marshall JM, Cederholm-Williams SA: Plasminogen: a structural review. Blood Coagul. Fibrinolysis 1992,3(5):605–614.PubMedCrossRef 52. Angles-Cano E: Overview Interleukin-3 receptor on fibrinolysis: plasminogen activation JNJ-26481585 pathways on fibrin and cell surfaces. Chem. Phys. Lipids 1994, 67–68:353–362.PubMedCrossRef 53. Angles-Cano E, de la Pena Diaz A, Loyau S: Inhibition of fibrinolysis by lipoprotein(a). Annals of the New York Academy of Sciences 2001, 936:261–75.PubMedCrossRef 54. Nakai K, Kanehisa M: Expert system for predicting protein localization sites in gram-negative bacteria. Proteins 1991,11(2):95–110.PubMedCrossRef 55. Finn RD, Mistry J, Schuster-Bockler B, Griffiths-Jones S, Hollich V, Lassmann T, Moxon S, Marshall M, Khanna A, Durbin R, et al.: Pfam: clans, web tools and services. Nucleic acids research 2006,34(Database issue):D247-D251.

Comments are closed.